Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuadrise Regulatory News (QED)

Share Price Information for Quadrise (QED)

Share Price is delayed by 15 minutes
Get Live Data
1.995    -0.215 (-9.73%)
Bid:
1.905
Ask:
2.19
Spread: 0.285 (14.961%)
Market Cap: £40.02m
QED Live PriceLast checked at - London Stock Exchange

Intraday Quadrise Share Chart

Form 8.5 (EPT/NON-RI) AMENDMENT - QUINTAIN ESTATES & DEVELOPMENT PLC

28 Aug 2015 16:56

FORM 8.5 (EPT/NON-RI) AMENDMENT TO PURCHASES

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN

EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY (“RI”) STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)

Rule 8.5 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Name of exempt principal trader: BARCLAYS CAPITAL SECURITIES LTD
(b) Name of offeror/offeree in relation to whose QUINTAIN ESTATES & DEVELOPMENT PLC
relevant securities this form relates:
(c) Name of the party to the offer with which exempt QUINTAIN ESTATES & DEVELOPMENT PLC
principal trader is connected
(d) Date position held/dealing undertaken: 24 August 2015
(e) In addition to the company in 1(b) above, is the exempt principal NO
trader making disclosures in respect of any other party to the offer?

2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: ORD
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 1,802,696 0.21% 704,194 0.13%
(2) Cash-settled derivatives:
0 0.00% 760,376 0.14%
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 0 0.00% 0 0.00%
TOTAL: 1,802,696 0.21% 1,464,570 0.28%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant Purchase/sale Total number of Highest price per unit Lowest price per unit
security securities paid/received paid/received
ORD Purchase 714,800 1.3000 GBP 1.2992 GBP
ORD Sale 701,542 1.3001 GBP 1.3 GBP

(b) Cash-settled derivative transactions

Class of Product Nature of dealing Number of Price per
relevant description reference unit
security securities
ORD CFD Short 13,258 1.2992 GBP

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit

(ii) Exercise

Class of relevant security Product description

e.g. call option

Exercising/ exercised against Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 28 Aug 2015
Contact name: Jay Supaya
Telephone number: 020 7773 0635

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: http://www.businesswire.com/news/home/20150828005468/en/

Copyright Business Wire 2015

Date   Source Headline
26th Mar 20157:00 amRNSSignificant holding in Company
19th Mar 20154:30 pmRNSDirector Declaration
19th Mar 20154:30 pmRNSDirector Declaration
10th Mar 201510:00 amRNSDirectors' Shareholdings
9th Mar 20154:30 pmRNSSignificant holding in Company
3rd Mar 20154:31 pmRNSTotal Voting Rights
3rd Mar 20154:30 pmRNSDirector Shareholding
13th Feb 20157:00 amRNSQ3 Trading Update
10th Feb 20154:30 pmRNSDirectors' Shareholdings
3rd Feb 20154:30 pmRNSDirector Shareholding
3rd Feb 20154:30 pmRNSTotal Voting Rights
21st Jan 20157:00 amRNSAppointment of Finance Director
16th Jan 20154:30 pmRNSHolding(s) in Company
7th Jan 20154:30 pmRNSDirector/PDMR Shareholding
5th Jan 20154:31 pmRNSTotal Voting Rights
5th Jan 20154:30 pmRNSDirector/PDMR Shareholding
10th Dec 20144:30 pmRNSDirector/PDMR Shareholding
2nd Dec 20144:31 pmRNSBlocklisting Interim Review
2nd Dec 20144:30 pmRNSTotal Voting Rights
2nd Dec 20144:30 pmRNSDirector/PDMR Shareholding
25th Nov 20147:00 amRNSInterim Results
10th Nov 20144:30 pmRNSDirector/PDMR Shareholding
4th Nov 20144:31 pmRNSTotal Voting Rights
4th Nov 20144:30 pmRNSDirector/PDMR Shareholding
28th Oct 20144:30 pmRNSHolding(s) in Company
28th Oct 201412:53 pmRNSNotice of Interim Results
8th Oct 20144:30 pmRNSDirector/PDMR Shareholding
7th Oct 20147:00 amRNSAnnouncement re: Board Announcement
3rd Oct 20149:31 amRNSTotal Voting Rights
3rd Oct 20149:30 amRNSDirector/PDMR Shareholding
15th Sep 201410:45 amRNSDirector/PDMR Shareholding
10th Sep 20144:30 pmRNSDirector/PDMR Shareholding
2nd Sep 20144:30 pmRNSDirector/PDMR Shareholding
2nd Sep 20144:30 pmRNSHolding(s) in Company
2nd Sep 20144:30 pmRNSTotal Voting Rights
22nd Aug 20144:30 pmRNSAudit Tender Outcome
8th Aug 20147:00 amRNSInterim Management Statement
7th Aug 20144:30 pmRNSDirector/PDMR Shareholding
4th Aug 20144:30 pmRNSDirector/PDMR Shareholding
4th Aug 20144:30 pmRNSTotal Voting Rights
4th Aug 20144:30 pmRNSChange of Registered Office
23rd Jul 20144:30 pmRNSHolding(s) in Company
22nd Jul 20145:29 pmRNSResult of AGM
21st Jul 20145:46 pmRNSAGM Statement
8th Jul 20145:12 pmRNSDirector/PDMR Shareholding
3rd Jul 20144:30 pmRNSHolding(s) in Company
2nd Jul 20144:30 pmRNSDirector/PDMR Shareholding
2nd Jul 20144:30 pmRNSTotal Voting Rights
30th Jun 20144:30 pmRNSDirector/PDMR Shareholding
20th Jun 20149:30 amRNSAnnual Report and Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.